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Background & aims: Previous studies have shown that dietary zinc intake is closely related to cardio-
vascular complications and metabolic derangements. However, the effect of dietary zinc intake on renal
function is not fully elucidated.
Methods: Data from the Korean Genome and Epidemiology Study were used. Dietary zinc intake was
assessed by a Food Frequency Questionnaire and dietary zinc density was calculated as absolute zinc
intake amount per daily energy intake (mg/1000 kcal day). The participants were categorized into
quartiles according to dietary zinc density. The primary end point was incident chronic kidney disease
(CKD), defined as estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73 m2.
Results: A total of 7735 participants with normal renal function was included in the final analysis. The
mean age was 52.0 ± 8.8 years, 47.5% were male, and mean eGFR was 92.1 ± 16.1 ml/min/1.73 m2. The
mean daily zinc intake and zinc intake density were 8.6 ± 3.4 mg and 4.4 ± 0.9 mg/1000 kcal, respec-
tively. During a median follow up of 11.5 (1.7e12.5) years and 70,617 person-years of observation, CKD
developed in 1409 (18.2%) participants. Multivariable cox hazard analysis revealed that risk for CKD
development was significantly higher in the quartile with a mean zinc intake density of 3.6 ± 0.2 mg/
1000 kcal compared with the quartile with a mean zinc intake density of 5.6 ± 1.0 mg/1000 kcal (Hazard
ratio; 1.36; 95% Confidence Interval 1.18e1.58; P < 0.001). This relationship remained significant even
after adjustments for confounding factors.
Conclusion: Low dietary zinc intake may increase the risk of CKD development in individuals with
normal renal function.
© 2020 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction health problem [2,6]. Since established CKD is an irrevocable con-Despite widespread treatment of diabetes and hypertension, the
two most recognized causes of chronic kidney disease (CKD), the
prevalence of CKD continues to rise rapidly worldwide [1,2]. CKD
leads to end stage renal disease and predisposition for cardiovas-
cular diseases and premature death [3e5]. Therefore, the
increasing number of CKD patients is considered a major publicedicine, College of Medicine,
ity, 50-1 Yonsei-ro, Seodae-
Ltd. This is an open access article udition, prevention by identifying modifiable risk factors is impor-
tant for reducing CKD-related morbidity and mortality.
Zinc is an essential trace element that has critical catalytic,
structural, and regulatory functions. Zinc is involved in many cat-
alytic activity of enzymes involved in replication of DNA, cell divi-
sion, energy metabolism, and growth [7,8]. In addition, zinc plays
key roles in maintaining protein structure and stability [9]. It is also
an essential component for maintaining cellular membrane struc-
ture and function [10]. Recent investigations have also identified
key roles for zinc in regulating antioxidant activity and leptin as
well as in insulin signaling [11e13]. Accordingly, zinc status has
been reported to be associated with several disease conditionsnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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increased mortality in patients with cardiovascular disease (CVD)
[18]. Dietary zinc supplementation has shown beneficial roles in
patients with chronic metabolic diseases [19]. Similarly, adequate
zinc consumption is associated with reduced blood pressure and
glucose control in Chinese diabetes and CVD patients [20]. Collec-
tively, these results suggest a close relationship between zinc
intake and metabolic and cardiovascular equanimity.
Despite the similar pathogenic mechanisms of kidney function
impairments and cardiovascular and metabolic diseases, the rela-
tionship between dietary zinc consumption and kidney function is
not well elucidated. Therefore, this study aimed to evaluate the
association between dietary zinc consumption and incident CKD
development in a prospective community-based cohort consisting
of normal renal function participants.
2. Subjects and methods
2.1. Ethical statements
This study was carried out in accordance with the Declaration of
Helsinki and was approved by the Institutional Review Board of the
Yonsei University Health System Clinical Trial Center (2019-1455-
0001).
2.2. Study population
Data were retrieved from the KoGES (Korean Genome and
Epidemiology Study), a prospective community-based study.
Detailed cohort profiles and methods concerning the development
of KoGES have been described elsewhere [21]. In brief, the study
cohort comprised middle aged (40e69 years old) participants who
reside in Ansan (an urban area) or Ansung (a rural area), cities near
Seoul, South Korea. The subjects underwent prearranged anthro-
pometric examinations, laboratory tests, and health-related
behavior surveys with an interview or questionnaire at baseline
and at biennial visits up to 14 years from study enrollment. For the
current study, subjects who had completed the FFQ at baseline
were included. Subjects with baseline eGFR <60 ml/min/1.73 m2,
known kidney disease, or proteinuria at baseline were excluded.
Participants who reported implausible daily energy intake
(<500 kcal/day or 5000 kcal/day) were also excluded.
2.3. Data collection
Details on data collection are described in the Supplemental
methods. Serum creatinine level was measured using the Jaffe
method throughout the study period. For the main analysis eGFR
was calculated using the MDRD equation [22]. For the sensitivity
analysis, eGFR calculated through the CKD Epidemiology Collabo-
ration (CKD-EPI) equationwas used [23]. The creatinine levels were
reduced by a calibration factor of 5% for standardization to isotope
dilution mass spectrometry reference method values for CKD-EPI
equation substitution [24,25]. Urine protein amounts were deter-
mined as absent, trace, 1þ, 2þ, or 3þ, which approximately corre-
late with urine protein levels of <10, 10e20, >30, >100, and
>500 mg/dL, respectively. The presence of proteinuria was
considered for a urinalysis result higher than trace level.
2.4. Dietary zinc measurements
Single-day dietary data for nutrients including zinc (mg) and
total calorie (kcal) intake were estimated based on semi quantita-
tive FFQ that was collected with the assistance of trained in-
terviewers by computer-based questionnaire programs orquestionnaire booklets [26]. The questionnaire consisted of a food
list that was leveled for nine intake frequencies and 3 intake
amounts. The FFQ was composed of 103 items selected from the
1998 Korean Health and Nutrition Examination Survey, a nation-
wide dietary survey representing the entire South Korean popula-
tion. For each food item questionnaire, the participant was asked to
select frequency ranging from “never/seldom” to “3 times per day”
for each food/dish or to “5 times or more per day” for beverages, as
well as the amount, ranging from “small” to “large,” of food they
consumed on average over the past year. A picture of each food/dish
was provided in the questionnaire so that the subject could easily
respond to the daily intake of each food item. Data were entered
into the cohort epidemiology information system, analyzed by a
nutrient database for each connected item, and systemically
designed to calculate nutrient and food intakes for each participant.
Total dietary nutrient component and calorie of each food item
were calculated based on the seventh edition of the Food Compo-
sition Tables of the Korean Nutrition Society [27]. The validity and
reproducibility for dietary zinc in this FFQ has been verified pre-
viously elsewhere [26,28]. Dietary zinc density was calculated as
absolute zinc intake amount per daily energy intake (mg/1000 kcal
day).
2.5. Outcome measurement
The primary endpoint was incident CKD development, which
was defined as eGFR <60 ml/min/1.73 m2 during the follow-up
period.
2.6. Statistical analysis
Baseline characteristics were stratified based on dietary zinc
density quartile. Cox proportional-hazards regression analysis was
used to evaluate the relationship between dietary zinc intake and
incident CKD development. To test the non-linearity relationship
between dietary zinc intake and incident CKD risk, restricted cubic
spline analyses were conducted with log-transformed zinc intake
as a continuous variable due to distribution of dietary zinc density.
The annual rate of renal function decline according to zinc intake
group was determined by the slope of eGFR obtained from a linear
mixed model. For sensitivity analysis, analyses were conducted
excluding those who were dropped out within 3 years after
enrollment. Evaluations using eGFR calculated through the CKD-EPI
equation were also performed as sensitivity analyses. All analyses
were performed by STATA (Version 16.1; Stata Corp, Texas, USA)
and R language (version 3.4.3; R Foundation for Statistical




In total, 7735 participants were included in the final analysis
(Supplemental Fig. 1). The baseline characteristics of the partici-
pants are shown in Table 1. The mean age was 52.0 ± 8.8 years, and
47.5% were male. The mean estimated glomerular filtration rate
(eGFR) was 92.1 ± 16.1 ml/min/1.73 m2. The mean daily zinc con-
sumption amount and daily energy intake were 8.6 ± 3.4 mg
(8.1 ± 3.2 mg for women and 9.0 ± 3.5 mg for men) and
1933 ± 600 kcal/day, respectively. Mean zinc consumption density,
calculated as amount of zinc intake per energy intake, was
4.4 ± 0.9 mg/1000 kcal. When stratified into quartiles by dietary
zinc density, participants with higher education and income were
allocated to the higher zinc consumption group. In contrast,
Table 1
Baseline characteristics according to dietary zinc density quartiles.
Total (N ¼ 7735) Quartiles of Zinc density P
Q1 (N ¼ 1934) Q2 (N ¼ 1934) Q3 (N ¼ 1934) Q4 (N ¼ 1933)
Zinc consumption
Absolute intake amount, mg 8.6 ± 3.4 6.6 ± 2.3 7.7 ± 2.4 8.8 ± 2.5 11.2 ± 4.0 <0.001
Intake density, mg/1000 kcal 4.4 ± 0.9 3.6 ± 0.2 4.0 ± 0.1 4.5 ± 0.1 5.6 ± 1.0 <0.001
Daily energy intake, kcal/day 1933 ± 600 1847 ± 623 1910 ± 581 1961 ± 564 2015 ± 616 <0.001
Vitamin & mineral supplement use 1487 (19.2) 269 (13.9) 367 (19.0) 414 (21.4) 437 (22.6) <0.001
Demographic data
Age, yr 52.0 ± 8.8 53.5 ± 9.0 52.3 ± 8.9 51.5 ± 8.5 50.8 ± 8.4 <0.001
Male 3676 (47.5) 855 (44.2) 861 (44.5) 916 (47.4) 1044 (54.0) <0.001
Education <0.001
Low 4332 (56.0) 1336 (69.1) 1154 (59.7) 1017 (52.6) 825 (42.7)
Mid 2635 (34.1) 503 (26.0) 634 (32.8) 682 (35.3) 816 (42.2)
High 768 (9.9) 95 (4.9) 146 (7.5) 235 (12.2) 292 (15.1)
Income per month, KRW <0.001
Low (<1 million) 3942 (51.0) 1303 (67.4) 1045 (54.0) 866 (44.8) 728 (37.7)
Mid (1e2 million) 2440 (31.5) 449 (23.2) 610 (31.5) 682 (35.3) 699 (36.2)
High (2 million) 1353 (17.5) 182 (9.4) 279 (14.4) 386 (20.0) 506 (26.2)
Married 6976 (90.2) 1683 (87.0) 1743 (90.1) 1761 (91.1) 1789 (92.6) <0.001
Smoking <0.001
Never 4561 (59.0) 1171 (60.5) 1178 (60.9) 1159 (59.9) 1053 (54.5)
Ever 1266 (16.4) 283 (14.6) 297 (15.4) 327 (16.9) 359 (18.6)
Current 1908 (24.7) 480 (24.8) 459 (23.7) 448 (23.2) 521 (27.0)
Current drinker 3683 (47.6) 778 (40.2) 896 (46.3) 944 (48.8) 1065 (55.1) <0.001
Daily physical activity, MET h 1446.9 ± 893.3 1597.3 ± 961.0 1451.2 ± 885.6 1415.0 ± 878.4 1327.3 ± 824.0 <0.001
BMI, kg/m2 24.6 ± 3.1 24.6 ± 3.3 24.5 ± 3.1 24.6 ± 3.0 24.6 ± 3.1 0.74
SBP, mmHg 120.4 ± 18.8 123.0 ± 19.3 120.2 ± 19.1 119.9 ± 18.3 118.7 ± 18.1 <0.001
DBP, mmHg 79.8 ± 12.1 80.9 ± 11.9 79.6 ± 12.0 79.4 ± 12.1 79.2 ± 12.1 <0.001
Comorbidities
Hypertension 2911 (37.6) 759 (39.2) 715 (37.0) 755 (39.0) 682 (35.3) 0.03
Diabetes 1999 (25.8) 467 (24.1) 503 (26.0) 522 (27.0) 507 (26.2) 0.22
CVD 227 (2.9) 61 (3.2) 64 (3.3) 45 (2.3) 57 (2.9) 0.29
Laboratory parameters
eGFR, ml/min/1.73 m2 92.1 ± 16.1 92.9 ± 15.6 92.7 ± 16.2 91.6 ± 16.0 91.1 ± 16.4 <0.001
Glucose, mg/dL 86.8 ± 20.4 85.0 ± 16.8 86.3 ± 19.2 87.5 ± 24.0 88.6 ± 20.7 <0.001
Albumin, g/dL 4.2 ± 0.3 4.2 ± 0.3 4.2 ± 0.3 4.3 ± 0.3 4.3 ± 0.3 <0.001
BUN, mg/dL 14.2 ± 3.5 14.0 ± 3.5 14.2 ± 3.6 14.2 ± 3.5 14.4 ± 3.4 0.03
Total cholesterol, mg/dL 190.8 ± 35.1 189.0 ± 34.6 189.3 ± 35.0 191.8 ± 35.6 193.1 ± 34.9 <0.001
HDL-C, mg/dL 44.0 (38.0e50.0) 43.0 (38.0e50.0) 43.5 (37.0e50.0) 44.0 (38.0e50.0) 43.0 (38.0e50.0) 0.29
Triglyceride, mg/dL 160.5 ± 102.8 161.7 ± 105.2 158.9 ± 98.8 161.3 ± 104.7 160.0 ± 102.3 0.82
CRP, mg/l 0.14 (0.06e0.24) 0.14 (0.06e0.25) 0.14 (0.06e0.24) 0.14 (0.06e0.23) 0.14 (0.07e0.24) 0.37
HBA1c, % 5.8 ± 0.9 5.7 ± 0.8 5.8 ± 0.9 5.8 ± 1.0 5.8 ± 0.9 0.19
HOMA-IR score 1.8 ± 1.4 1.8 ± 1.4 1.8 ± 1.7 1.7 ± 1.3 1.8 ± 1.1 0.80
Note: All continuous variables are expressed as mean ± SD, median (interquartile range), or proportion n (percentage).
Abbreviations: KRW, Korean Won; BMI, body mass index; MET, metabolic equivalent of task; SBP, systolic blood pressure; DBP, diastolic blood pressure; CVD, cardiovascular
disease; eGFR, estimated glomerular filtration; BUN, Blood urea nitrogen; HDL-C, high-density lipoprotein cholesterol; CRP, C-reactive protein; HBA1c, glycated hemoglobin;
HOMA-IR, Homeostatic model assessment-insulin resistance.
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lower eGFR and physical activity. Absolute zinc intake amount in-
creases proportionally with zinc density quartile.
3.2. Development of incident CKD
During a median follow up of 11.5 (1.7e12.5) years and 70,617
person-years of observation, CKD developed in 1409 (18.2%) par-
ticipants. The overall incidence rate of CKD was 20.0 (95% confi-
dence interval [95% CI], 18.9e21.0) per 1000 person-years. The CKD
development rate tended to be lower in subjects with higher di-
etary zinc density (P for trend ¼ 0.001) (Fig. 1).
3.3. Impact of dietary zinc consumption on incident CKD
development
The association of incident CKD risk and dietary zinc density
was assessed using multivariable Cox regression models (Table 2).
The risk of CKD development was significantly higher in the lowest
zinc consumption group participants compared with the highestquartile group subjects (hazard ratio [HR], 1.36; 95% CI 1.18e1.58,
P < 0.001). This association was robust even after adjustments for
clinical, anthropometric, and laboratory confounding factors (HR,
1.20; 95% CI 1.04e1.40, P ¼ 0.02).
To test the non-linearity association between zinc consumption
amount and risk of incident CKD, restrictive cubic spline analyses
were further conducted. A significant increase in HR for CKD
development was noted when dietary zinc density was less than
4.4 mg/1000 kcal. In addition, the HR gradually increased with a
decrease in dietary zinc density (Fig. 2).3.4. Difference in the annual renal function decline rate among the
zinc consumption groups
During the follow-up duration, eGFR declined at an average rate
of 1.31 (95% CI, 1.33 to 1.28) ml/min/1.73 m2 per year. Kidney
function declined at a faster rate in the lowest zinc density quartile
compared to the highest quartile (1.43 vs 1.18 ml/min/1.73 m2
per year, P < 0.001) (Table 3).
Fig. 1. Outcomes according to quartile of dietary zinc density.
Table 2
Risk of chronic kidney disease in quartile groups of dietary zinc consumption.
Models Dietary zinc density quartile
Q1 Q2 Q3 Q4
HR (95% CI) P HR (95% CI) P HR (95% CI) P
1 1.36 (1.18e1.58) <0.001 1.10 (0.94e1.28) 0.25 1.12 (0.96e1.30) 0.15 Reference
2 1.20 (1.03e1.40) 0.02 1.02 (0.87e1.19) 0.83 1.06 (0.91e1.24) 0.42
3 1.25 (1.07e1.46) 0.005 1.05 (0.90e1.22) 0.56 1.10 (0.94e1.28) 0.25
4 1.20 (1.04e1.40) 0.02 1.01 (0.87e1.18) 0.87 1.10 (0.94e1.28) 0.92
Note: model 1: adjusted for age, sex, eGFR, vitamin & mineral supplement use, and total energy intake.
Model 2: model 1 þ BMI, systolic blood pressure, education, income, diabetes, and cardiovascular disease.
Model 3: model 2 þ C-reactive protein, HDL-C, and HOMA-IR score.
Model 4: model 3 þ smoking status, alcohol consumption, and physical activity.
C-reactive protein, HDL-C, and HOMA-IR were log-transformed due to skewed distribution.
Abbreviations: HR, hazard ratio; CI, confidence interval; eGFR, estimated glomerular filtration rate; BMI, body mass index; HDL-C, high-density lipoprotein; HOMA-IR, ho-
meostatic model assessment-insulin resistance.
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The relationship between zinc consumption amount and inci-
dent CKD was further evaluated in subgroups stratified by age (<60
or60 years), sex (male or female), BMI (<25 kg/m2 or25 kg/m2),
diabetes (with or without), and hypertension (with or without). No
significant interaction was found in any of the subgroups, sug-
gesting that the relationship between zinc consumption and inci-
dent CKD risk was consistently significant across subgroups (Fig. 3).
3.6. Sensitivity analysis
Evaluations excluding subjects with a shorter than 3-year
follow-up duration, yielded results consistent with the main anal-
ysis (Supplemental Table 1). In addition, evaluations were also
made with eGFR values obtained through the CKD-EPI equation.
Analyses evaluating CKD incidence, development risk, and renal
function decline rate all revealed results similar to the main anal-
ysis (Supplemental Figs. 2 and 3, and Supplemental Tables 2 and 3).4. Discussion
In this study, dietary zinc intake was significantly associated
with incident CKD risk among the general population with pre-
served renal function. The CKD incidence rate was higher in lower
dietary zinc consuming participants. In addition, risk of CKD
development significantly increased in those whose dietary zinc
intake was lower compared with average zinc-consuming in-
dividuals. This risk elevation was independent of confounding
factors including total energy intake, comorbidities, and body
anthropometric features.
Several approaches were used to examine the relationship be-
tween dietary zinc and CKD development. Comparing chronic
kidney disease incidence among dietary zinc quartiles allows an
estimation of the relationship between dietary zinc and kidney
function. However, it is difficult to conclude an independent asso-
ciation with incidence comparison alone. On the other hand, Cox
regression analysis and annual eGFR decline rate comparison in-
tensifies the independent relationship between dietary zinc and
Fig. 2. Restricted cubic spline plot for incident chronic kidney disease according to dietary zinc density. Note: Adjusted for age, sex, eGFR, BMI, SBP, vitamin & mineral supplement
use, education, income, diabetes, CVD, CRP, HDL-C, BMI, smoking status, HOMA-IR score, alcohol consumption, and physical activity. Mean zinc intake amount was considered as
reference. Abbreviations: eGFR, estimated glomerular filtration rate; BMI, body mass index; SBP, systolic blood pressure; CVD, cardiovascular disease; CRP, C-reactive protein; HDL-
C, high-density lipoprotein cholesterol; BMI, body mass index; HOMA-IR, homeostatic model assessment for insulin resistance.
Table 3
Annual rate of renal function decline according to dietary zinc density quartiles.
Zinc density quartile Slopes of eGFR decline (ml/min/1.73 m2 per year) P
Quartile 1 1.43 (1.48 to 1.38) <0.001
Quartile 2 1.37 (1.42 to 1.32) <0.001
Quartile 3 1.25 (1.30 to 1.20) 0.07
Quartile 4 1.18 (1.23 to 1.14) Reference
Note: Adjusted for age, sex, eGFR, BMI, SBP, vitamin & mineral supplement use, education, income, diabetes, CVD, CRP, HDL-C, BMI, smoking
status, HOMA-IR score, alcohol consumption, and physical activity.
Abbreviations: eGFR, estimated glomerular filtration rate; BMI, body mass index; SBP, systolic blood pressure; CVD, cardiovascular disease;
CRP, C-reactive protein; HDL-C, high-density lipoprotein cholesterol; BMI, body mass index; HOMA-IR, homeostatic model assessment for
insulin resistance.
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dietary zinc consumption increases the risk of CKD development,
while the annual eGFR decline rate comparison results show that
the actual kidney function decline is steeper which ultimately leads
to higher CKD event rates. The cubic spline analysis further visu-
alizes the dietary zinc consumption and CKD development risk.
Zinc intake is related with development and progression of
several chronic metabolic diseases [29e31]. In particular, a close
association between insulin resistance and blood pressure has been
repeatedly reported [17,20,32]. In a cross-sectional study of 3575
Indian participants, low zinc intake was associated with higher
prevalence of coronary artery disease, diabetes, and altered meta-
bolic surrogate markers [17]. Similarly, in 12,028 Chinese partici-
pants, adequate zinc consumption was associated with reduced
diastolic blood pressure and fasting glucose levels in females [20].
Concordantly, in this study, systolic blood pressure and diastolic
blood pressure were significantly higher in those consuming smaller
amounts of zinc. In addition, metabolic syndrome was more preva-
lent among lower zinc-consuming participants, supporting the
previously reported link between dietary zinc and metabolic
derangement [17].One of the main strengths of this study is the prospective design.
Dietary habits are bound to change when CKD is diagnosed. There-
fore, it is noteworthy that the dietary data were collected prior to
development of CKD in participants with normal kidney function. In
addition, since kidney function decline usually shows an indolent
progress, the long follow-up duration is an indispensable advanta-
geous characteristic of the study. Moreover, the population-based
cohort, which consisted of relatively healthy participants compared
with hospital-based studies, and the considerably large sample size,
should also be noticed as a merit.
This study has several limitations. First, food frequency question-
naire (FFQ) was surveyed only at baseline. Therefore, the diet pattern
changes over time could not be considered in the analysis. Second,
serum zinc concentration level was not available. However, serum
zinc level has been found to be a poor surrogate of body zinc ho-
meostasis [33]. This is supported by the fact that serum zinc level is
not associated with chronic metabolic disease, although there is an
accumulation of reports showing a positive link between dietary zinc
and poor outcome. Third, data on zinc supplementation was not
available. However, information on vitamin & mineral supplemen-
tation in general was included in the analyses which would have
Fig. 3. Forest plots for subgroup analyses of incident CKD development according to quartile of zinc consumption. Note: Adjusted for age, sex, eGFR, BMI, SBP, vitamin & mineral
supplement use, education, income, diabetes, CVD, CRP, HDL-C, BMI, smoking status, HOMA-IR score, alcohol consumption, and physical activity. Abbreviations: CKD, chronic renal
disease; CI, confidence interval; BMI; body mass index; DM, diabetes mellitus; HTN, hypertension.
Y.S. Joo et al. / Clinical Nutrition 40 (2021) 1039e10451044lowered the chances of bias to some extent. Fourth, the participants
consisted of an Asian population in a single country. Since dietary
habits vary among ethnicity and cultural backgrounds, further in-
vestigations including other cultures are needed to generalize the
results. In particular, the zinc consumption amount in this study was
somewhat lower than that reported in Western countries [34,35].
Nonetheless, the reported amount still corresponds to the Korean
Recommended Nutrient Intake (RNI) for zinc [36]. Finally, a clear
causal relationship between zinc consumption and incident CKD
could not be ascertained due to the observational nature of this study.
In conclusion, in this community-based prospective cohort of
participants with preserved renal function, low zinc intake wasassociated with a significantly increased risk of incident CKD.
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